Genetic Technologies Launches geneType Risk Assessment Portfolio Globally On EasyDNA Platform, Expanding Reach To 42 Countries And Potentially Boosting A$7.5M Annual Revenues
Portfolio Pulse from Benzinga Newsdesk
Genetic Technologies has launched its geneType Risk Assessment Portfolio globally on the EasyDNA platform, expanding its reach to 42 countries. This expansion is expected to potentially boost annual revenues by A$7.5 million.
August 15, 2024 | 12:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Genetic Technologies has launched its geneType Risk Assessment Portfolio globally on the EasyDNA platform, expanding its reach to 42 countries. This expansion is expected to potentially boost annual revenues by A$7.5 million.
The global launch of the geneType Risk Assessment Portfolio on the EasyDNA platform significantly expands Genetic Technologies' market reach to 42 countries. This expansion is expected to increase annual revenues by A$7.5 million, which is a positive indicator for the company's financial performance and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100